Abstract
In 1998, two distinct and exciting scientific fields emerged which have profoundly shaped the current direction of biomedical research. The discovery of RNA interference (RNAi) and the derivation of human embryonic stem (ES) cells have yielded exciting new possibilities for researchers and clinicians alike. While fundamentally different, aspects from these two fields may be combined to yield extraordinary scientific and medical benefits. Here, we review the prospects of combining RNAi and ES cell manipulation for both basic research and future therapies, as well as current limitations and obstacles that need to be overcome.
Original language | English (US) |
---|---|
Pages (from-to) | 478-486 |
Number of pages | 9 |
Journal | Gene Therapy |
Volume | 13 |
Issue number | 6 |
DOIs | |
State | Published - Mar 2006 |
Keywords
- Cell-replacement therapy
- Differentiation
- ES cells
- RNAi
- miRNA
- siRNA
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology
- Genetics